CAR-T Cells Targeting CLL-1 as an Approach to Treat Acute Myeloid Leukemia

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-017-0553-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Compound CAR T-Cells as a Double-Pronged Approach for Treating Acute Myeloid Leukemia

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2018English

CAR T Cells for Acute Lymphoblastic Leukemia

American Journal of Hematology
Hematology
2019English

An Auristatin Nanoconjugate Targeting CXCR4+ Leukemic Cells Blocks Acute Myeloid Leukemia Dissemination

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2020English

CAR-T Cells: An Innovative Therapeutic Strategy Against Pediatric Acute Lymphoblastic Leukemia

Research in Molecular Medicine (RMM)
2019English

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Do We Treat Like an Acute Myeloid Leukemia?

Case Reports in Hematology
2019English

How I Treat Older Patients With Acute Myeloid Leukemia

Cancer
Cancer ResearchOncology
2018English

AML1 (Acute Myeloid Leukemia 1)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2010English

Chronic Lymphocytic Leukemia (CLL) Cells Genetically Modified to Express B7-1, ICAM-1, and LFA-3 Confer APC Capacity to T Cells From CLL Patients

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy